Estrone cyanate

From WikiMD's WELLNESSPEDIA

Estrone_cyanate.svg

Estrone cyanate is a synthetic estrogen and a derivative of estrone. It is classified as an estrogen ester and is specifically the 3-cyanate ester of estrone. Estrone cyanate is known for its potential use in hormone replacement therapy and other medical applications related to estrogen deficiency.

Chemical Structure and Properties[edit]

Estrone cyanate has the chemical formula C19H21NO2. It is derived from estrone, a naturally occurring estrogen, by the addition of a cyanate group at the 3-position of the steroid nucleus. This modification alters the pharmacokinetics and pharmacodynamics of the molecule, potentially affecting its bioavailability and metabolism.

Mechanism of Action[edit]

As an estrogen, estrone cyanate binds to and activates the estrogen receptors (ERs) in various tissues. This activation leads to the modulation of gene expression and the regulation of numerous physiological processes, including the development and maintenance of female secondary sexual characteristics, regulation of the menstrual cycle, and maintenance of bone density.

Medical Uses[edit]

Estrone cyanate has been investigated for its use in hormone replacement therapy (HRT) for the treatment of symptoms associated with menopause, such as hot flashes, vaginal atrophy, and osteoporosis. It may also be used in the management of hypoestrogenism due to various causes, including ovarian failure and hypogonadism.

Pharmacokinetics[edit]

The pharmacokinetics of estrone cyanate involve its absorption, distribution, metabolism, and excretion. As an ester of estrone, it is likely hydrolyzed in the body to release the active hormone, estrone. The exact pharmacokinetic profile, including its half-life, bioavailability, and metabolic pathways, would depend on the specific formulation and route of administration.

Side Effects[edit]

Like other estrogens, estrone cyanate may cause side effects, including but not limited to nausea, breast tenderness, headache, and fluid retention. Long-term use of estrogens has been associated with an increased risk of endometrial cancer, breast cancer, and cardiovascular disease. Therefore, the use of estrone cyanate should be carefully monitored by a healthcare provider.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.